A Carnot Institute is a research organization which places partnership research led with, and for, industry, at the heart of its strategy. Carnot institutes are recognized for both their high scientific standards and their professionalism and commitment to developing high quality partnership research.
The Institut Carnot Pasteur Microbes & Santé
Since 2007, Institut Carnot Pasteur Microbes & Santé has met global public health challenges by developing research applications and transferring technological solutions to industry.
As a major player in research on infectious and chronic diseases, Institut Carnot Pasteur Microbes & Santé aims to work with industry partners to promote the development of innovative products in the fields of therapeutics, diagnostics, vaccines and biotechnology.
In partnership with its Scientific Steering Committee and based on various selection processes, Institut Carnot Pasteur Microbes & Santé funds:
- Scientific resourcing initiatives to develop innovative research projects.
- Partnership development or maturation initiatives to advance technologies from proof of concept to innovation and even industrial transfer, and to generate economic value.
- Carnot scheme integration initiatives, i.e. projects conducted with another Carnot Institute – France Futur Elevage – to combine expertise and foster interdisciplinarity.
Interdisciplinarity and integrative approach
The action of Institut Carnot Pasteur Microbes & Santé is structured around 4 themes, each of which forms a continuum between fundamental, applied and translational research: emerging infectious diseases; antimicrobial resistance; microbiota and non-communicable diseases; interface with mathematics, physics and chemistry.
Infectious diseases are a major industrial and public health issue, and remain the focus of core actions carried out by Institut Carnot Pasteur Microbes & Santé.
Its scope consists of six Institut Pasteur departments that primarily deal with infectious diseases (Cell Biology and Infection, Global Health, Microbiology, Parasites and Insect Vectors, Virology and Mycology), in association with several immunology, neuroscience, structural biology and chemistry units. Interdisciplinarity is key to identifying new therapeutic and diagnostic strategies, particularly for diseases involving the immune system (chronic infection, autoimmune diseases) or of neurodegenerative and cerebral origin (Alzheimer's and Parkinson's in particular).
Innovative technologies applied to biology, such as chemogenomic screening, imaging and microfluidics, are sources of innovation that open up new perspectives in biomedical research, in particular the identification of new biomarkers or therapeutic targets. Consequently, several units and technological platforms are also part of Institut Carnot Pasteur Microbes & Santé.
The Institut Pasteur's Innovation Accelerator integrated within Institut Carnot Pasteur Microbes & Santé, supports various projects with high potential and valuable assets for transfer to industry. By combining funding strategies, technical support and business expertise, the Innovation Accelerator aims to reduce technological development times in terms of licensing and commercialization of scientific discoveries.